top of page

PIONeeR Project's team

WP0 – Coordination

Denis-Bertin-Team.jpg

Pr. Denis Bertin

Aix-Marseille Université

Deputy Chairman of the Foundation A*Midex

Fabrice-Barlesi-Team.jpg

Pr. Fabrice Barlesi

Université Paris-Saclay, Institut Gustave Roussy

Coordinator of the PIONeeR Project RHU

WP1 – Clinical Studies

Pascale-Tomasini-Team.jpg

Dr. Pascale Tomasini

Aix-Marseille Université, AP-HM
Investigational clinical center of Marseille
Principal investigator-study coordinator of
the early phase randomized umbrella clinical trial

Co-leader du WP1

Laurent-Greiller-team (1).jpg

Pr. Laurent Greiller

Aix-Marseille Université, AP-HM
Investigational clinical center of Marseille (and satellite centers)
Principal investigator-study coordinator of the biomarkers protocol

Co-leader du WP1

Alexandra-Guliani-Team.jpg

Alexandra Giuliani

DRS APHM – Sponsor
Project manager of the two PIONeeR clinical studies
(regulatory documents, budget, logistics and human resources)

Marryannick-Le-Ray-Team (1).jpg

Dr. Maryannick Le Ray

DRS APHM – Sponsor
CRA-coordinator
Redaction of regulatory documents, patients
(inclusions, e-CRF)
& samples follow-up in connection with academic
and industrial analysis platforms

Julien-Mazie-Team.jpg

Pr. Julien Mazières

Hôpitaux de Toulouse-Université Paul Sabatier
Investigational clinical center of the Toulouse University Hospital (and satellite centers)
Co-principal investigator of the biomarkers protocol and of the early phase randomized umbrella clinical trial

Maurice-Perol-Team.jpg

Dr. Maurice Pérol

Centre Léon Bérard (CLB)
Investigational clinical center of the CLB Lyon (and satellite centers)
Co-principal investigator of the biomarkers protocol and of the early phase randomized umbrella clinical trial

Sylvie-Chabaud-Team.jpg

Sylvie Chabaud

Centre Léon Bérard (CLB)
Investigational clinical center of the CLB Lyon (and satellite centers)
Co-principal investigator of the biomarkers protocol and of the early phase randomized umbrella clinical trial

Claire-Cropet-Team.jpg

Claire Cropet

Centre Léon Bérard (CLB)
Investigational clinical center of the CLB Lyon (and satellite centers)
Co-principal investigator of the biomarkers protocol and of the early phase randomized umbrella clinical trial

Ozan-OK.jpg

Dr Nicolas Ozan

AstraZeneca
Medical Director Oncology France
Link between AZ teams in the US & the UK, and the AP-HM
and RHU coordination teams (supply, regulatory and legal aspects of experimental molecules)

David-Perol-Team.jpg

Dr. David Perol

Centre Léon Bérard (CLB)
Clinical Research and Innovation Department
Study design and statistical analysis of the
early phase randomized umbrella clinical trial

WP2 – Biomarkers

FMontville.jpg

Dr. Florence Monville

Veracyte
Coordinator of the Biomarkers profiling program (blood, tumors, feces)

Vanina-Leca-Team.jpg

Dr. Vanina Leca

Veracyte
Biomarkers profiling program (blood, tumors, feces)

JP-Dales-Team.jpg

Jean Philippe Dales

Aix-Marseille Université, AP-HM
APHM anatomopathology department
Centralized collection and processing of
tumor samples from the PIONeeR protocols

Fred-Vely-Team.jpg

Dr. Frédéric Vély

Aix-Marseille Université, AP-HM
MI/AP-HM immuno-profiling platform
Immunoprofiling of soluble and cellular biomarkers
from PIONeeR patient blood samples

Amélie-Pouchin-team.png

Amélie Pouchin

Aix-Marseille Université, AP-HM
MI/AP-HM immuno-profiling platform
Immunoprofiling of soluble and cellular biomarkers
from PIONeeR patient blood samples

Florence-Sabatier-Team.jpg

Pr. Florence Sabatier

Aix Marseille Université AP-HM
Vasculo-monitoring platform of APHM
Study of the link between immunotherapy and
the endothelial compartment in PIONeeR patients

Laurent-Arnaud-Team.jpg

Laurent Arnaud

Engineer – AP-HM
Vasculo-monitoring platform of APHM
Study of the link between immunotherapy and
the endothelial compartment in PIONeeR patients

Joseph-Ciccollini-Team-1.jpg

Pr. Joseph Ciccolini

Aix-Marseille Université, APHM
Centre de Recherche en Cancérologie de Marseille (CRCM)- SMARTc laboratory
Clinical pharmacokinetics and toxicology department
PK-PD study and modeling

Sivan-ok.jpg

Dr. Sivan Bokobza

Manager IHC, Innate Pharma
Tissue biomarkers profiling by immuno-histochemistry

Benzekry-OK.jpg

Inria – Inserm team COMPO (CRCM)
Biostatistician
Biostatistical, integrative (machine learning)
and mechanistic analyses of the PIONeeR BioMarkers protocol and
mathematical modeling of the response to immunotherapies

WP3 – New immune-checkpoint modulators candidates

Eric-Vivier-Team.jpg

Pr. Eric Vivier

Aix-Marseille Université, APHM,

Centre d’Immunologie de Marseille Luminy (CIML), Innate Pharma

WP3 co-leader

Pierre-Milpied-Team.jpg

Dr. Pierre Milpied

Inserm, Centre d’Immunologie de Marseille Luminy (CIML)
Characterization of anti-tumor activity of B lymphocytes

WP3 co-leader

Co-Leader of WP3

Emilie-Narni-Mancinelli-Team.jpg

Dr. Emilie Narni-Mancinelli

Inserm, Centre d’Immunologie de Marseille Luminy (CIML)

Evaluation of the NKP44/46 pathway in anti-tumor immunity

Daniel-Olive-Team.jpg

Pr. Daniel Olive

Aix-Marseille Université, IPC, CRCM

Evaluation of the BTLA/HVEM pathway in anti-tumor immunity

Co-Leader du WP3

Emmanuel-Valentin-Team.jpg

Dr. Emmanuel Valentin

ImCheck Therapeutics

Evaluation of the BTLA/HVEM pathway in anti-tumor immunity

Anna-Zarubica-Team.jpg

Dr. Ana Zarubica

CIPHE platform
Evaluation of the BTLA/HVEM pathway in anti-tumor immunity
Generation and immunophenotyping of transgenic mouse models

WP4 – Communication and exploitation

ATCG (1).jpg

Dr. Jean Philippe Tissier-Seta
Céline Voisin
Marie Puvieux

ATCG-Partners

Communication et dissémination scientifique

bottom of page